| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | ALDER BIOPHARMACEUTICALS INC | 33,000 | 824,000 | 0.16% | ||
| 102 | ENDO INTL PLC | 52,000 | 811,000 | 0.15% | ||
| 103 | PROSHARES TR | 20,500 | 796,000 | 0.15% | ||
| 104 | QUOTIENT LTD | 100,000 | 775,000 | 0.15% | ||
| 105 | CELLDEX THERAPEUTICS INC NEW | 160,000 | 702,000 | 0.13% | ||
| 106 | KITE PHARMA INCORPORATED | 14,000 | 700,000 | 0.13% | ||
| 107 | UNITED THERAPEUTICS CORP DEL | 6,300 | 667,000 | 0.13% | ||
| 108 | TEAM HEALTH HOLDINGS INC | 15,000 | 610,000 | 0.11% | ||
| 109 | COMMUNITY HEALTH SYS INC NEW | 50,000 | 603,000 | 0.11% | ||
| 110 | NEVRO CORP COM | 7,500 | 553,000 | 0.10% | ||
| 111 | RESMED INC | 8,000 | 506,000 | 0.10% | ||
| 112 | INSULET CORPORATION | 15,000 | 454,000 | 0.09% | ||
| 113 | MYRIAD GENETICS INC | 14,000 | 428,000 | 0.08% | ||
| 114 | Esperion Therapeutics Inc | 40,000 | 395,000 | 0.07% | ||
| 115 | PENUMBRA INC COM | 5,000 | 298,000 | 0.06% | ||
| 116 | TENET HEALTHCARE CORP | 10,000 | 276,000 | 0.05% | ||
| 117 | SURGERY PARTNERS INCORPORATED | 15,000 | 269,000 | 0.05% | ||
| 118 | Theravance Biopharma Inc | 11,428 | 259,000 | 0.05% | ||
| 119 | Heartware International, Inc. | 3,813 | 220,000 | 0.04% | ||
| 120 | INFINITY PHARMACEUTICALS INC | 160,000 | 213,000 | 0.04% | ||
| 121 | QUORUM HEALTH CORP | 12,500 | 134,000 | 0.03% | ||
| 122 | ZAFGEN INC COM | 20,000 | 120,000 | 0.02% | ||
| 123 | TETRAPHASE PHARMACEUTICALS INC COM | 22,000 | 95,000 | 0.02% | ||
| 124 | EIGER BIOPHARMACEUTICALS INC | 3,333 | 66,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-019825, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
